Literature DB >> 2442413

Analysis of middle tumor antigen and pp60c-src interactions in polyomavirus-transformed rat cells.

J B Bolen, V DeSeau, J O'Shaughnessy, S Amini.   

Abstract

The relative abundance of pp60c-src molecules associated with polyomavirus (Py) middle tumor antigen (MTAg) and the relative abundance of MTAg associated with pp60c-src in a variety of Py-transformed rat cells was determined by quantitative immunoblot analyses which detect pp60c-src or Py MTAg. The results demonstrate that approximately 5 to 10% of the total immunoprecipitable pp60c-src molecules in Py-transformed rat cells are stably associated with MTAg and have elevated protein kinase activities. In these same cells, it was found that approximately 10 to 15% of the detectable MTAg molecules are stably associated with pp60c-src. Other results presented in this report demonstrate that approximately 50 to 75% of the total MTAg-associated cellular tyrosine kinase activity potentially represents the enzymatic activity of pp60c-src, while the remaining 25 to 50% represents the activity of other cellular tyrosine kinases. Our results also show that most pp60c-src molecules associated with Py MTAg do not possess electrophoretic mobilities that are altered from those of pp60c-src molecules not associated with MTAg or pp60c-src molecules obtained from normal rodent cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442413      PMCID: PMC255913     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Protein kinase activity associated with polyoma virus middle T antigen in vitro.

Authors:  A E Smith; R Smith; B Griffin; M Fried
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

2.  Viable deletion mutant in the medium and large T-antigen-coding sequences of the polyoma virus genome.

Authors:  M M Bendig; T Thomas; W R Folk
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

3.  Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes, associated protein kinase activities, and cell transformation.

Authors:  G G Carmichael; B S Schaffhausen; D I Dorsky; D B Oliver; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

4.  Early mutants of polyoma virus (dl8 and dl23) with altered transformation properties: is polyoma virus middle T antigen a transforming gene product?

Authors:  B E Griffin; Y Ito; U Novak; N Spurr; S Dilworth; N Smolar; R Pollack; K Smith; D B Rifkin
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

5.  Mutation causing premature termination of the polyoma virus medium T antigen blocks cell transformation.

Authors:  D Templeton; W Eckhart
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

6.  Coding potential and regulatory signals of the polyoma virus genome.

Authors:  E Soeda; J R Arrand; N Smolar; J E Walsh; B E Griffin
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

7.  An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates.

Authors:  W Eckhart; M A Hutchinson; T Hunter
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

8.  Phosphorylation of polyoma T antigens.

Authors:  B S Schaffhausen; T L Benjamin
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

9.  Virus-specific proteins in the plasma membrane of cells lytically infected or transformed by pol-oma virus.

Authors:  Y Ito; J R Brocklehurst; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

10.  Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein.

Authors:  R Treisman; U Novak; J Favaloro; R Kamen
Journal:  Nature       Date:  1981-08-13       Impact factor: 49.962

View more
  14 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

Review 2.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

3.  A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity.

Authors:  B J Druker; L E Ling; B Cohen; T M Roberts; B S Schaffhausen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Polyomavirus middle-T antigen associates with the kinase domain of Src-related tyrosine kinases.

Authors:  N M Dunant; M Senften; K Ballmer-Hofer
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis.

Authors:  Tamara Utermark; Trisha Rao; Hailing Cheng; Qi Wang; Sang Hyun Lee; Zhigang C Wang; J Dirk Iglehart; Thomas M Roberts; William J Muller; Jean J Zhao
Journal:  Genes Dev       Date:  2012-07-15       Impact factor: 11.361

6.  Polyomavirus transforms rat F111 and mouse NIH 3T3 cells by different mechanisms.

Authors:  L Raptis; J B Bolen
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

7.  p56lck protein-tyrosine kinase is cytoskeletal and does not bind to polyomavirus middle T antigen.

Authors:  R R Louie; C S King; A MacAuley; J D Marth; R M Perlmutter; W Eckhart; J A Cooper
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

8.  Association of p60fyn with middle tumor antigen in murine polyomavirus-transformed rat cells.

Authors:  I D Horak; T Kawakami; F Gregory; K C Robbins; J B Bolen
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  Regulation of pp60c-src and its interaction with polyomavirus middle T antigen in insect cells.

Authors:  H Piwnica-Worms; N G Williams; S H Cheng; T M Roberts
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

10.  Polyomavirus middle T-antigen NPTY mutants.

Authors:  B J Druker; L Sibert; T M Roberts
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.